Harvest Fund Management Co., Ltd - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Harvest Fund Management Co., Ltd ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$51
-75.1%
574
-76.2%
0.01%
-78.0%
Q2 2023$205
+83.0%
2,411
+78.7%
0.04%
+64.0%
Q1 2023$112
+202.7%
1,349
+185.8%
0.02%
+150.0%
Q4 2022$37
-99.9%
4720.0%0.01%0.0%
Q3 2022$35,000
+191.7%
472
+84.4%
0.01%
+900.0%
Q4 2019$12,000
-92.2%
256
-78.9%
0.00%
-95.0%
Q3 2019$153,000
+264.3%
1,213
+247.6%
0.02%
+300.0%
Q2 2019$42,000
-85.7%
349
-88.1%
0.01%
-91.8%
Q4 2018$293,000
-48.6%
2,929
-41.1%
0.06%
-37.8%
Q3 2018$570,0004,9750.10%
Other shareholders
HAEMONETICS CORP shareholders Q3 2018
NameSharesValueWeighting ↓
Bridge City Capital, LLC 40,541$5,114,0002.20%
Lisanti Capital Growth, LLC 53,385$6,734,0002.20%
Nitorum Capital, L.P. 279,510$35,257,0002.05%
CROWN ADVISORS MANAGEMENT, INC. 20,000$2,523,0001.69%
Millrace Asset Group, Inc. 11,400$1,438,0001.69%
COOKSON PEIRCE & CO INC 145,884$18,402,0001.61%
Endurant Capital Management LP 32,594$4,111,0001.48%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 111,000$14,002,0001.38%
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 110,065$13,884,0001.37%
EMERALD ADVISERS, LLC 203,640$25,687,0001.20%
View complete list of HAEMONETICS CORP shareholders